Colorectal Cancer Awareness in Turkey
July 15, 2019 updated by: Cemile Idiz, Istanbul University
Assessment of Colorectal Cancer Awareness in Patients Admitted to the General Surgery Outpatient Clinic
Colorectal cancer is among the most common types of cancer worldwide.
Population-based screening programs for breast, cervical, and colorectal cancer have been introduced as part of cancer control in many high-income countries.
Population-based cancer screening programs do not exist in most low- and middle-income countries.
There are some studies that report the awareness of colorectal cancer in Turkey.
Study Overview
Detailed Description
Colorectal cancer is the third most common type of cancer in both men and women.
According to World Health Organization data, in 2012, 694 thousand people were thought to be due to colorectal cancer and this number increased to 862 thousand people in 2018.
Especially in most low- and middle-income countries where cancers are mainly detected through very-late-stage symptoms and many are not reported.
Recent researches may lead to new approaches to early detection and treatment using improved awareness of the symptomatic disease and population-based screening of asymptomatic people.
The increasing of colorectal cancer awareness could help early detection of colorectal cancers.
In this study, the investigators aimed to determine the level of awareness of colorectal cancer and knowledge about colorectal cancer screenings in patients who applied to general surgery outpatients clinic where a colorectal cancer diagnosis was most frequently diagnosed.
Study Type
Observational
Enrollment (Anticipated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 34098
- Recruiting
- Istanbul Training and Research Hospital
-
Contact:
- Coskun Cakir, MD
- Phone Number: +905054405493
- Email: c_cakir@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
Patients who apply to the general surgery outpatient clinic with any diseases.
Description
Inclusion Criteria:
- Patients who apply to the general surgery outpatients clinic
Exclusion Criteria:
- Younger than 18 years old
- Older than 80 years old
- Mental retardation or other mental illness
- Refusing to join the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Survey
All of the patients that enrolled in this study will be in this group.
|
A survey with 13 questions will be applied to the patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The awareness of patients about colorectal cancer
Time Frame: 3 months
|
To assess the awareness of patients about colorectal cancer with a survey
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Coskun Cakir, MD, Istanbul Training and Research Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Andsoy II, Gul A. Breast, cervix and colorectal cancer knowledge among nurses in Turkey. Asian Pac J Cancer Prev. 2014;15(5):2267-72. doi: 10.7314/apjcp.2014.15.5.2267.
- Kaya O, Hoca O, Kulacoglu H. Knowledge and awareness of auxiliary health personnel about colorectal cancer. Turk J Gastroenterol. 2013;24(4):339-44. doi: 10.4318/tjg.2013.0631.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2019
Primary Completion (Anticipated)
July 31, 2019
Study Completion (Anticipated)
August 15, 2019
Study Registration Dates
First Submitted
July 12, 2019
First Submitted That Met QC Criteria
July 15, 2019
First Posted (Actual)
July 16, 2019
Study Record Updates
Last Update Posted (Actual)
July 16, 2019
Last Update Submitted That Met QC Criteria
July 15, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Colorectal Cancer
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
In case of request individual participant data could be shared with other researchers
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.